Under this task order, the contractor will independently provide support services to satisfy the overalloperational objectives of the national cancer institute, center for cancer research. The primary…
Ended Awarded Last action
- Contract number
- 75N91021F00007
- Awardee
-
Astrix Technology LLC UEI NRVNN8E6NCK4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $152,150
Award facts
- Contract value 98% obligated
-
- $152,150.24 Current, with exercised options
- $154,650.24 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,500 | |
| Funding Only Action | -$3,458 | |
| Original award | $158,108 |
About this award
The National Cancer Institute issued a BPA call to Astrix Technology LLC on October 26, 2020, with a ceiling value of $154,650.24 under the GSA Multiple Award Schedule (MAS). The call required the contractor to provide scientific support services to the National Cancer Institute's Center for Cancer Research, with performance in Bethesda, Maryland. Ultimate completion was October 24, 2021. The work was also designated to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability for those funds. The contract carried firm fixed price terms.
Description
Under this task order, the contractor will independently provide support services to satisfy the overalloperational objectives of the national cancer institute, center for cancer research. The primary objective is to provide services and deliverables
Quick answers
Who was awarded contract 75N91021F00007?
75N91021F00007 was awarded to Astrix Technology LLC by National Cancer Institute (National Institutes of Health) on October 26, 2020.
How much is contract 75N91021F00007 worth?
The government has obligated $152,150 on 75N91021F00007. Its potential value, with all options, is $154,650.
Is contract 75N91021F00007 an order under another contract?
Yes. 75N91021F00007 is a BPA call under GS07F147DA-HHSN261201700002B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75N91021F00007 competed?
The extent of competition for 75N91021F00007 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award